cGAMP loading enhances the immunogenicity of VLP vaccines
Authors:
- Lise ChauveauLCLise Chauveau
- Anne BridgemanABAnne Bridgeman
- Tiong Kit TanTTTiong Kit Tan
- Ryan BeveridgeRBRyan Beveridge
- Joe FrostJFJoe Frost
- Isabela Pedroza-PachecoIPIsabela Pedroza-Pacheco
- Thomas PartridgeTPThomas Partridge
- Persephone BorrowPBPersephone Borrow
- Hal DrakesmithHDHal Drakesmith
- Alain TownsendATAlain Townsend
- Jan RehwinkelJRJan Rehwinkel
Preprint
- 3 January 2020
- preprint
- Published by Cold Spring Harbor Laboratory in bioRxiv
Abstract
Cyclic GMP-AMP (cGAMP) is an immunostimulatory second messenger produced by cGAS that activates STING. Soluble cGAMP acts as an adjuvant when administered with antigens. cGAMP is also incorporated into enveloped virus particles during budding. We hypothesised that inclusion of the adjuvant cGAMP within viral vaccine vectors would promote adaptive immunity against vector antigens. We immunised mice with virus-like particles (VLPs) containing the HIV-1 Gag protein and VSV-G. Inclusion of cGAMP within these VLPs augmented splenic VLP-specific CD4 and CD8 T cell responses. It also increased VLP- and VSV-G-specific serum antibody titres and enhancedin vitrovirus neutralisation. The superior antibody response was accompanied by increased numbers of T follicular helper cells in draining lymph nodes. Vaccination with cGAMP-loaded VLPs containing haemagglutinin induced high titres of influenza A virus neutralising antibodies and conferred protection following subsequent influenza A virus challenge. Together, these results show that incorporating cGAMP into VLPs enhances their immunogenicity, making cGAMP-VLPs an attractive platform for novel vaccination strategies.Short summary: cGAMP is an innate immune signalling molecule that can be transmitted between cells by inclusion in enveloped virions. This study demonstrates enhanced immunogenicity of HIV-derived virus-like particles containing cGAMP. Viral vectors loaded with cGAMP may thus be potent vaccines.Keywords
This publication has 56 references indexed in Scilit:
- T Follicular Helper Cell Biology: A Decade of Discovery and DiseasesImmunity, 2019
- 2’3’-cGAMP is an immunotransmitter produced by cancer cells and regulated by ENPP1bioRxiv, 2019
- Viruses transfer the antiviral second messenger cGAMP between cellsScience, 2015
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and ImmunityCell Reports, 2015
- The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively activates pinocytosis-efficient cells in vivoeLife, 2015
- The cGAS-cGAMP-STING Pathway of Cytosolic DNA Sensing and SignalingMolecular Cell, 2014
- MPYS/STING-Mediated TNF-α, Not Type I IFN, Is Essential for the Mucosal Adjuvant Activity of (3′–5′)-Cyclic-Di-Guanosine-Monophosphate In VivoThe Journal of Immunology, 2014
- cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STINGNature, 2013
- STING is a direct innate immune sensor of cyclic di-GMPNature, 2011
- Vaccine Adjuvants: Putting Innate Immunity to WorkImmunity, 2010